Funder: National Institutes of Health (NIH)
Due Dates: May 27, 2026 (Estimated, forecasted opportunity)
Funding Amounts: Award size not specified; cooperative agreement; multi-year, multi-project funding expected
Summary: Supports collaborative research teams to develop and clinically test novel therapies for adult glioblastoma, focusing on agents that cross the blood-brain barrier.
Key Information: Forecasted opportunity—dates and details subject to change; check program page for updates.